Addex Therapeutics ADXN
NASDAQ ADXN
$3.07 -0.04 (-1.29%)
At close: Oct 23, 2026 · 4:00 PM EDT

Addex Therapeutics (ADXN) Cash & Current Investments (2017 - 2026)

Updated

Addex Therapeutics' Cash & Current Investments was $975,894 in Q2 2026, down 65.0% from $2.79 million a year earlier and down 18.5% from the prior quarter.

Analysis

Addex Therapeutics (ADXN) Cash & Current Investments (2017 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Addex Therapeutics came in at $2.06 million, down 46.0% from FY2024.

  • Cash & Current Investments has now declined for six consecutive years, with a five-year compound annual growth rate of -43.3% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $3.81 million in FY2024 (-51.5%), $7.84 million in FY2023 (-63.1%), $21.27 million in FY2022 (-4.5%) and $22.27 million in FY2021 (-36.3%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Current Investments in data going back to Q4 2017.
  • Compared with a year earlier, Cash & Current Investments has declined for five straight quarters, with an average decline of 25.9% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q1 2025 (growth of 68.7%); the worst was Q1 2024 (a decline of 69.1%).
  • Per Business Quant data, ADXN's Cash & Current Investments in the three quarters before Q2 2026 was $1.2 million (Q1 2026), $2.06 million (Q4 2025) and $2.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Addex Therapeutics 3.78 Mn -3.17 Mn - 955,066.80
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 955,066.80
Mar 31, 2026 1.17 Mn
Dec 31, 2025 2.08 Mn
Sep 30, 2025 2.75 Mn
Jun 30, 2025 2.89 Mn
Mar 31, 2025 3.22 Mn
Dec 31, 2024 3.71 Mn
Sep 30, 2024 3.99 Mn
Jun 30, 2024 4.22 Mn
Mar 31, 2024 1.81 Mn
Dec 31, 2023 4.58 Mn
Sep 30, 2023 5.20 Mn
Jun 30, 2023 7.99 Mn
Mar 31, 2023 6.13 Mn
Dec 31, 2022 7.54 Mn
Sep 30, 2022 10.69 Mn
Jun 30, 2022 9.24 Mn
Mar 31, 2022 16.14 Mn
Dec 31, 2021 22.44 Mn
Sep 30, 2021 16.61 Mn
API Access

Addex Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ADXN&period=max&api_key=YOUR_API_KEY